Skip to main content
Caplight Logo









EnFuego Therapeutics Inc.

EnFuego Therapeutics Inc.

Private
Pittsboro, North CarolinaHealthcare & Life Scienceshttps://enfuegotherapeutics.com/

Last Round

Grant

Jul 1, 2024

Total Funding Raised

$2.05M

Company Overview

EnFuego Therapeutics Inc. is a drug discovery company developing RNA interference-based and antisense oligo therapeutics to treat lung, pancreatic, and colon cancers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

RNAi therapeuticsgene silencingKRAS mutationsKRAS targeted therapysiRNA therapeuticsRNA interferenceundruggable targetsoncogene targetingprecision medicinedrug discoverypreclinical biotechnologypancreatic cancerlung cancercolon canceruniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnFuego Therapeutics Inc. Comparables

Compare EnFuego Therapeutics Inc. with similar companies based on industry and business-model similarity.

EnFuego Therapeutics Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Silexion Therapeutics Corp.
78%
VesiCURE Therapeutics
77%
Kestrel Therapeutics
73%

EnFuego Therapeutics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2024
SeedJun 15, 2021
AcceleratorMay 21, 2020
GrantMar 16, 2020

EnFuego Therapeutics Inc. Investors

Notable investors and investment history

EnFuego Therapeutics Inc. investors
InvestorRounds
National Cancer InstituteGrant
KickStart Venture ServicesAccelerator
NIH RADxGrant
North Carolina Biotechnology CenterGrant
Fox VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2024

    $919K grant received from National Cancer Institute and NIH RADx.

  • Jun 15, 2021

    $500K raised with Fox Ventures participating.

EnFuego Therapeutics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EnFuego Therapeutics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EnFuego Therapeutics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPittsboro, North Carolina
Year Founded2019
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?